BioRestorative Therapies: director Donald J. Currie appointed

What happened The filing says the board of BioRestorative Therapies, Inc. appointed Donald J. Currie as a Class I director on Oct 7, 2026, effective immediately, to fill the vacancy created by the resignation of Katharyn Field effective Aug 31, 2026. The filing says Mr. Currie will serve until the Company’s 2027 annual meeting of stockholders and until his successor is duly elected and qualified or his earlier death, resignation or removal.

Key details

• The board appointed Mr. Currie as a member of the nominating and corporate governance committee and the compensation committee.
• The filing says the board determined Mr. Currie to be an “independent director” under Nasdaq rules and Rule 10A-3 under the Exchange Act.
• Mr. Currie, age 65, has served as CEO and a director of Hillcrest Energy Technologies Ltd. since Feb 2010 and has more than 30 years of experience in the energy sector; the filing says he has not held any other position or served as a director of any other company during the past five years.
• As compensation, the filing says Mr. Currie will receive CAD $2,000 per month, payable monthly in arrears, and will be reimbursed for reasonable out-of-pocket expenses; the filing says he will not participate in the Company’s standard non-employee director compensation program. The filing also says the Company expects to enter into an indemnification agreement with Mr. Currie.

Why it may matter The filing was submitted under Item 5.02, which reports departures of directors or certain officers and the election or appointment of directors; it covers the appointment, committee assignments, independence determination and compensation for the new director. The filing does not show why the insider traded or why the company acted.